Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


Articles published in Virus Res

Retrieve available abstracts of 105 articles:
HTML format



Single Articles


    June 2021
  1. GHOSH N, Saha I, Sharma N, Nandi S, et al
    Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.
    Virus Res. 2021;298:198401.
    PubMed     Abstract available


    May 2021
  2. LEE S, Won D, Kim CK, Ahn J, et al
    Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.
    Virus Res. 2021;297:198398.
    PubMed     Abstract available


  3. HASAN MM, Das R, Rasheduzzaman M, Hussain MH, et al
    Global and local mutations in Bangladeshi SARS-CoV-2 genomes.
    Virus Res. 2021;297:198390.
    PubMed     Abstract available


    April 2021
  4. FRANCISCO RDS JR, Benites LF, Lamarca AP, de Almeida LGP, et al
    Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.
    Virus Res. 2021;296:198345.
    PubMed     Abstract available


  5. MIRANDA RL, Guterres A, de Azeredo Lima CH, Filho PN, et al
    Misinterpretation of viral load in COVID-19 clinical outcomes.
    Virus Res. 2021;296:198340.
    PubMed     Abstract available


  6. LI JY, Wang Q, Liao CH, Qiu Y, et al
    The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.
    Virus Res. 2021;295:198307.
    PubMed     Abstract available


  7. SCAGNOLARI C, Pierangeli A, Frasca F, Bitossi C, et al
    Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).
    Virus Res. 2021;295:198283.
    PubMed     Abstract available


  8. HU Z, Zhao J, Shi L, Hu J, et al
    Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Virus Res. 2021;298:198409.
    PubMed     Abstract available


    March 2021
  9. LANDGRAF G, Desheva YA, Rudenko LG
    Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
    Virus Res. 2021 Mar 17:198396. doi: 10.1016/j.virusres.2021.198396.
    PubMed     Abstract available


  10. MIYAOKA Y, Kabir H, Hasan A, Yamaguchi M, et al
    Virucidal activity of slightly acidic hypochlorous acid water toward influenza virus and coronavirus with tests simulating practical usage.
    Virus Res. 2021 Mar 8:198383. doi: 10.1016/j.virusres.2021.198383.
    PubMed     Abstract available


  11. SAFARI F, Afarid M, Rastegari B, Borhani-Haghighi A, et al
    CRISPR systems: Novel approaches for detection and combating COVID-19.
    Virus Res. 2021;294:198282.
    PubMed     Abstract available


  12. TAN J, Yuan Y, Xu C, Song C, et al
    A retrospective comparison of drugs against COVID-19.
    Virus Res. 2021;294:198262.
    PubMed     Abstract available


    February 2021
  13. KIM DH, Park BJ, Ahn HS, Go HJ, et al
    Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus.
    Virus Res. 2021 Feb 16:198342. doi: 10.1016/j.virusres.2021.198342.
    PubMed     Abstract available


  14. RIVERA-BAHENA GB, Marquez-Bandala AH, Lopez-Guerrero DV, Esquivel-Guadarrama FR, et al
    TGF-beta1 signaling inhibit the in vitro apoptotic, infection and stimulatory cell response induced by influenza H1N1 virus infection on A549 cells.
    Virus Res. 2021 Feb 10:198337. doi: 10.1016/j.virusres.2021.198337.
    PubMed     Abstract available


  15. LI B, Xiang G, He J, Li H, et al
    H7N9 influenza virus surveillance in Gansu, China in 2017.
    Virus Res. 2021 Feb 9:198335. doi: 10.1016/j.virusres.2021.198335.
    PubMed     Abstract available


  16. DE CONTO F, Conversano F, Razin SV, Belletti S, et al
    Host-cell dependent role of phosphorylated keratin 8 during influenza A/NWS/33 virus (H1N1) infection in mammalian cells.
    Virus Res. 2021 Feb 5:198333. doi: 10.1016/j.virusres.2021.198333.
    PubMed     Abstract available


  17. AKIYAMA Y, Sakashita K, Arihara M, Kimura Y, et al
    COVID-19 infection in Hokkaido, Japan might depend on the viscosity of atmospheric air.
    Virus Res. 2021;293:198259.
    PubMed     Abstract available


  18. ITO G, Morikawa M, Akimoto S, Masatani T, et al
    Establishment of a safe and convenient assay for detection of HA subtype-specific antibodies with PB2 gene-knockout influenza viruses.
    Virus Res. 2021 Feb 1:198331. doi: 10.1016/j.virusres.2021.198331.
    PubMed     Abstract available


    January 2021
  19. LUBAN J, Sattler RA, Muhlberger E, Graci JD, et al
    The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines.
    Virus Res. 2021;292:198246.
    PubMed     Abstract available


  20. KUMAR R, Rathi H, Haq A, Wimalawansa SJ, et al
    Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Virus Res. 2021;292:198235.
    PubMed     Abstract available


  21. JOONLASAK K, Batty EM, Kochakarn T, Panthan B, et al
    Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.
    Virus Res. 2021;292:198233.
    PubMed     Abstract available


  22. MALEK A, Hoque A
    Trends of 2019-nCoV in South Asian countries and prediction of the epidemic peaks.
    Virus Res. 2021;292:198230.
    PubMed     Abstract available


  23. CATTEL F, Giordano S, Bertiond C, Lupia T, et al
    Ozone therapy in COVID-19: A narrative review.
    Virus Res. 2021;291:198207.
    PubMed     Abstract available


  24. PIERETTI JC, Rubilar O, Weller RB, Tortella GR, et al
    Nitric oxide (NO) and nanoparticles - Potential small tools for the war against COVID-19 and other human coronavirus infections.
    Virus Res. 2021;291:198202.
    PubMed     Abstract available


  25. CABBAB ILN, Manalo RVM
    Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection.
    Virus Res. 2021;291:198190.
    PubMed     Abstract available


    December 2020
  26. TAHAGHOGHI-HAJGHORBANI S, Zafari P, Masoumi E, Rajabinejad M, et al
    The role of dysregulated immune responses in COVID-19 pathogenesis.
    Virus Res. 2020;290:198197.
    PubMed     Abstract available


  27. RAJEEV R, Prathiviraj R, Kiran GS, Selvin J, et al
    Zoonotic evolution and implications of microbiome in viral transmission and infection.
    Virus Res. 2020;290:198175.
    PubMed     Abstract available


  28. KILLICK R, Ballard C, Doherty P, Williams G, et al
    Transcription-based drug repurposing for COVID-19.
    Virus Res. 2020;290:198176.
    PubMed     Abstract available


  29. KHARE P, Sahu U, Pandey SC, Samant M, et al
    Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Virus Res. 2020;290:198169.
    PubMed     Abstract available


  30. FREIRE-PASPUEL B, Vega-Marino P, Velez A, Cruz M, et al
    "Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit".
    Virus Res. 2020;290:198173.
    PubMed     Abstract available


  31. YAMASAKI Y, Ooka S, Tsuchida T, Nakamura Y, et al
    The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.
    Virus Res. 2020;290:198089.
    PubMed     Abstract available


    November 2020
  32. WEBER S, Ramirez C, Doerfler W
    Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.
    Virus Res. 2020;289:198170.
    PubMed     Abstract available


  33. GADOTTI AC, de Castro Deus M, Telles JP, Wind R, et al
    IFN-gamma is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.
    Virus Res. 2020;289:198171.
    PubMed     Abstract available


  34. RANGEL HR, Ortega JT, Maksoud S, Pujol FH, et al
    SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
    Virus Res. 2020;289:198154.
    PubMed     Abstract available


  35. ELHABYAN A, Elyaacoub S, Sanad E, Abukhadra A, et al
    The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
    Virus Res. 2020;289:198163.
    PubMed     Abstract available


  36. WANG X, Zheng J, Guo L, Yao H, et al
    Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis.
    Virus Res. 2020;289:198147.
    PubMed     Abstract available


  37. MARDANI R, Alamdary A, Mousavi Nasab SD, Gholami R, et al
    Association of vitamin D with the modulation of the disease severity in COVID-19.
    Virus Res. 2020;289:198148.
    PubMed     Abstract available


  38. CHOUDHARY S, Silakari O
    Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
    Virus Res. 2020;289:198146.
    PubMed     Abstract available


    October 2020
  39. ZHOU Y, Wu X, Yan D, Chen C, et al
    V292I Mutation in PB2 Polymerase Induces Increased Effects of E627K on Influenza H7N9 Virus Replication in Cells.
    Virus Res. 2020 Oct 16:198186. doi: 10.1016/j.virusres.2020.198186.
    PubMed     Abstract available


  40. YOKOYAMA Y, Briasoulis A, Takagi H, Kuno T, et al
    Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
    Virus Res. 2020;288:198137.
    PubMed     Abstract available


  41. ALI Z, Aman R, Mahas A, Rao GS, et al
    iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
    Virus Res. 2020;288:198129.
    PubMed     Abstract available


  42. DUTTA R, Buragohain L, Borah P
    Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
    Virus Res. 2020;288:198113.
    PubMed     Abstract available


  43. MOHAMMAD T, Shamsi A, Anwar S, Umair M, et al
    Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
    Virus Res. 2020;288:198102.
    PubMed     Abstract available


  44. SITARAS I, Spackman E, de Jong MCM, Parris DJ, et al
    Selection and Antigenic Characterization of Immune-Escape Mutants of H7N2 Low Pathogenic Avian Influenza Virus Using Homologous Polyclonal Sera.
    Virus Res. 2020 Oct 9:198188. doi: 10.1016/j.virusres.2020.198188.
    PubMed     Abstract available


  45. BAHRAMPOUR JUYBARI K, Pourhanifeh MH, Hosseinzadeh A, Hemati K, et al
    Melatonin potentials against viral infections including COVID-19: Current evidence and new findings.
    Virus Res. 2020;287:198108.
    PubMed     Abstract available


  46. VAN DEN HOOGEN B, Santoni A, Sciume G, Bowie A, et al
    Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
    Virus Res. 2020;287:198094.
    PubMed     Abstract available


  47. KESZEI Z, Vendrell XM, Soultsioti M, Molina PR, et al
    100 days of solitude: The spring of COVID-19 through the eyes of 15 young virologists of the INITIATE program.
    Virus Res. 2020;287:198093.
    PubMed    


  48. NIE Q, Li X, Chen W, Liu D, et al
    Phylogenetic and phylodynamic analyses of SARS-CoV-2.
    Virus Res. 2020;287:198098.
    PubMed     Abstract available


    September 2020
  49. AHLAWAT S, Asha, Sharma KK
    Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
    Virus Res. 2020;286:198103.
    PubMed     Abstract available


  50. LI C, Wang L, Ren L
    Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
    Virus Res. 2020;286:198073.
    PubMed     Abstract available


  51. MAGRO G
    COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.
    Virus Res. 2020;286:198070.
    PubMed     Abstract available


  52. ROMEO A, Iacovelli F, Falconi M
    Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Virus Res. 2020;286:198068.
    PubMed     Abstract available


  53. PAN X, Dong L, Yang L, Chen D, et al
    Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.
    Virus Res. 2020;286:198057.
    PubMed     Abstract available


  54. BEHLOUL N, Baha S, Shi R, Meng J, et al
    Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
    Virus Res. 2020;286:198058.
    PubMed     Abstract available


  55. LI J, Wei X, Tian W, Zou J, et al
    Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.
    Virus Res. 2020;286:198047.
    PubMed    


  56. LI J, Gong X, Wang Z, Chen R, et al
    Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China.
    Virus Res. 2020;286:198043.
    PubMed     Abstract available


  57. POST A, Dullaart RPF, Bakker SJL
    Sodium status and kidney involvement during COVID-19 infection.
    Virus Res. 2020;286:198034.
    PubMed     Abstract available


    August 2020
  58. SAMRAT SK, Tharappel AM, Li Z, Li H, et al
    Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
    Virus Res. 2020 Aug 23:198141. doi: 10.1016/j.virusres.2020.198141.
    PubMed     Abstract available


  59. WENJUN M
    Swine Influenza Virus: Current Status and Challenge.
    Virus Res. 2020 Aug 13:198118. doi: 10.1016/j.virusres.2020.198118.
    PubMed     Abstract available


  60. KAUR SP, Gupta V
    COVID-19 Vaccine: A comprehensive status report.
    Virus Res. 2020 Aug 12:198114. doi: 10.1016/j.virusres.2020.198114.
    PubMed     Abstract available


  61. DHAR D, Mohanty A
    Gut microbiota and Covid-19- possible link and implications.
    Virus Res. 2020;285:198018.
    PubMed     Abstract available


  62. ONAWOLE AT, Sulaiman KO, Kolapo TU, Akinde FO, et al
    COVID-19: CADD to the rescue.
    Virus Res. 2020;285:198022.
    PubMed     Abstract available


  63. ZHU X, Ge Y, Wu T, Zhao K, et al
    Co-infection with respiratory pathogens among COVID-2019 cases.
    Virus Res. 2020;285:198005.
    PubMed     Abstract available


  64. WANG Y, Song W, Zhao Z, Chen P, et al
    The impacts of viral inactivating methods on quantitative RT-PCR for COVID-19.
    Virus Res. 2020;285:197988.
    PubMed     Abstract available


    July 2020
  65. MANI JS, Johnson JB, Steel JC, Broszczak DA, et al
    Natural product-derived phytochemicals as potential agents against coronaviruses: A review.
    Virus Res. 2020;284:197989.
    PubMed     Abstract available


  66. ABUSALAMAH H, Reel JM, Lupfer CR
    Pyruvate Affects Inflammatory Responses of Macrophages During Influenza A Virus Infection.
    Virus Res. 2020 Jul 4:198088. doi: 10.1016/j.virusres.2020.198088.
    PubMed     Abstract available


  67. LIN L, Ting S, Yufei H, Wendong L, et al
    Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Virus Res. 2020 Jul 1:198082. doi: 10.1016/j.virusres.2020.198082.
    PubMed     Abstract available


    June 2020
  68. FANG A, Bi Z, Ye H, Yan L, et al
    SRSF10 inhibits the polymerase activity and replication of avian influenza virus by regulating the alternative splicing of chicken ANP32A.
    Virus Res. 2020 Jun 20:198063. doi: 10.1016/j.virusres.2020.198063.
    PubMed     Abstract available


    March 2020
  69. GODBOLE NM, Sinha RA, Tiwari S, Pawar SD, et al
    Analysis of influenza virus-induced perturbation in autophagic flux and its modulation during Vitamin D3 mediated anti-apoptotic signaling.
    Virus Res. 2020 Mar 28:197936. doi: 10.1016/j.virusres.2020.197936.
    PubMed     Abstract available


    January 2020
  70. ZHENG B, Zhou J, Wang H
    Host microRNAs and exosomes that modulate influenza virus infection.
    Virus Res. 2020 Jan 22:197885. doi: 10.1016/j.virusres.2020.197885.
    PubMed     Abstract available


    December 2019
  71. DE VRIES RD, Nieuwkoop NJ, Krammer F, Hu B, et al
    Analysis Of The Vaccine-Induced Influenza B Virus Hemagglutinin-Specific Antibody Dependent Cellular Cytotoxicity Response.
    Virus Res. 2019 Dec 11:197839. doi: 10.1016/j.virusres.2019.197839.
    PubMed     Abstract available


    October 2019
  72. LIU Y, Xie W, Chi M, Wen H, et al
    Mutations in the HRB linker of Human Parainfluenza Virus Type 3 Fusion Protein Reveal its Importance for Fusion Activity.
    Virus Res. 2019 Oct 16:197791. doi: 10.1016/j.virusres.2019.197791.
    PubMed     Abstract available


    August 2019
  73. VAZQUEZ-PEREZ JA, De La Rosa-Zamboni D, Vega-Sanchez Angel E, Gutierrez-Gonzalez LH, et al
    Amino acid changes in HA and determinants of pathogenicity associated with influenza virus A H1N1pdm09 during the winter seasons 2015-2016 and 2016-2017 in Mexico.
    Virus Res. 2019;272:197731.
    PubMed     Abstract available


    June 2019
  74. LEEMANS A, Boeren M, Van der Gucht W, Martinet W, et al
    Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
    Virus Res. 2019;266:58-68.
    PubMed     Abstract available


    March 2019
  75. HSIEH MS, Chang YC, He JL, Juang RH, et al
    Positive charge of Arg-201 on hemagglutinin is required for the binding of H6N1 avian influenza virus to its target through a two-step process.
    Virus Res. 2019;265:132-137.
    PubMed     Abstract available


  76. KODE SS, Pawar SD, Cherian SS, Tare DS, et al
    Selection of avian influenza A (H9N2) virus with reduced susceptibility to neuraminidase inhibitors oseltamivir and zanamivir.
    Virus Res. 2019 Mar 22. pii: S0168-1702(18)30554.
    PubMed     Abstract available


    February 2019
  77. ILYUSHINA NA, Dickensheets H, Donnelly RP
    A comparison of interferon gene expression induced by influenza A virus infection of human airway epithelial cells from two different donors.
    Virus Res. 2019 Feb 16. pii: S0168-1702(18)30652.
    PubMed     Abstract available


    January 2019
  78. BO F, Yang WT, Shonyela SM, Jin YB, et al
    Immune responses of mice inoculated with recombinant Lactobacillus plantarum NC8 expressing the fusion gene HA2 and 3M2e of the influenza virus and protection against different subtypes of influenza virus.
    Virus Res. 2019 Jan 3. pii: S0168-1702(18)30308.
    PubMed     Abstract available


    December 2018
  79. GAO J, Gao L, Li R, Lai Z, et al
    Integrated analysis of microRNA-mRNA expression in A549 cells infected with influenza A viruses (IAVs) from different host species.
    Virus Res. 2018 Dec 31. pii: S0168-1702(18)30568.
    PubMed     Abstract available


    October 2018
  80. MOHEBBI A, Fotouhi F, Jamali A, Yaghobi R, et al
    Molecular Epidemiology of the Hemagglutinin gene of prevalent influenza virus A/H1N1/pdm09 among patient in Iran.
    Virus Res. 2018 Oct 15. pii: S0168-1702(18)30478.
    PubMed     Abstract available


    September 2018
  81. MARUYAMA H, Kimura T, Liu H, Ohtsuki S, et al
    Influenza virus replication raises the temperature of cells.
    Virus Res. 2018 Sep 21. pii: S0168-1702(17)30886.
    PubMed     Abstract available


  82. HUO C, Jin Y, Zou S, Qi P, et al
    Lethal influenza A virus preferentially activates TLR3 and triggers a severe inflammatory response.
    Virus Res. 2018 Sep 21. pii: S0168-1702(18)30215.
    PubMed     Abstract available


    May 2018
  83. LUO J, Lu G, Ye S, Ou J, et al
    Comparative pathogenesis of H3N2 canine influenza virus in beagle dogs challenged by intranasal and intratracheal inoculation.
    Virus Res. 2018 May 31. pii: S0168-1702(18)30084.
    PubMed     Abstract available


  84. ZHANG F, Wang S, Wang Y, Shang X, et al
    Characterization of pseudoparticles paired with hemagglutinin and neuraminidase from highly pathogenic H5N1 influenza and avian influenza A (H7N9) viruses.
    Virus Res. 2018;253:20-27.
    PubMed     Abstract available


  85. RUDNEVA IA, Timofeeva TA, Mukasheva EA, Ignatieva AV, et al
    Pleiotropic effects of hemagglutinin amino acid substitutions of influenza A(H1N1)pdm09 virus escape mutants.
    Virus Res. 2018;251:91-97.
    PubMed     Abstract available


  86. CHEN L, Xing C, Ma G, Luo J, et al
    N-Myc Downstream-Regulated Gene 1 Facilitates Influenza A Virus Replication by Suppressing Canonical NF-kappaB Signaling.
    Virus Res. 2018 May 3. pii: S0168-1702(17)30905.
    PubMed     Abstract available


  87. SHOKOUHI H, Farahmand B, Ghaemi A, Mazaheri V, et al
    Vaccination with three tandem repeats of M2 extracellular domain fused to Leismania major HSP70 protects mice against influenza A virus challenge.
    Virus Res. 2018;251:40-46.
    PubMed     Abstract available


    March 2018
  88. SUPTAWIWAT O, Kongchanagul A, Boonarkart C, Auewarakul P, et al
    H1N1 seasonal influenza virus evolutionary rate changed over time.
    Virus Res. 2018 Mar 30. pii: S0168-1702(17)30881.
    PubMed     Abstract available


  89. ZHANG D, Lin G, Zhang K, Yi L, et al
    Implications of and lessons learned from external assurance of eight influenza diagnostics in China.
    Virus Res. 2018;249:110-115.
    PubMed     Abstract available


    February 2018
  90. CHOI SY, Cho B
    Extermination of influenza virus H1N1 by a new visible-light-induced photocatalyst under fluorescent light.
    Virus Res. 2018 Feb 21. pii: S0168-1702(17)30789.
    PubMed     Abstract available


    January 2018
  91. KALENIK BM, Gora-Sochacka A, Sirko A
    Beta-defensins - Underestimated peptides in influenza combat.
    Virus Res. 2018;247:10-14.
    PubMed     Abstract available


  92. KIM Y, Chang KO
    Protein Disulfide Isomerases as potential therapeutic targets for Influenza A and B Viruses.
    Virus Res. 2018 Jan 27. pii: S0168-1702(17)30675.
    PubMed     Abstract available


    November 2017
  93. YU Z, Cheng K, Sun W, Zhang X, et al
    Multiple adaptive amino acid substitutions increase the virulence of a wild waterfowl-origin reassortant H5N8 avian influenza virus in mice.
    Virus Res. 2017 Nov 4. pii: S0168-1702(17)30493.
    PubMed     Abstract available


    September 2017
  94. WANG Y, Zhang Y, Wu J, Lin Y, et al
    Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.
    Virus Res. 2017;242:16-23.
    PubMed     Abstract available


    July 2017
  95. PLANT EP, Ilyushina NA, Sheikh F, Donnelly RP, et al
    Influenza Virus NS1 Protein Mutations at Position 171 Impact Innate Interferon Responses by Respiratory Epithelial Cells.
    Virus Res. 2017 Jul 27. pii: S0168-1702(17)30201.
    PubMed     Abstract available


  96. KHAN A, Mushtaq MH, Ahmad MUD, Nazir J, et al
    Molecular Epidemiology of a novel re-assorted epidemic strain of equine influenza virus in Pakistan in 2015-16.
    Virus Res. 2017 Jul 27. pii: S0168-1702(17)30256.
    PubMed     Abstract available


    June 2017
  97. MANITO ACB, Graf T, Lunge VR, Ikuta N, et al
    Spatiotemporal dynamics of influenza A(H1N1)pdm09 in Brazil during the pandemic and post-pandemic periods.
    Virus Res. 2017 Jun 3. pii: S0168-1702(17)30047.
    PubMed     Abstract available


  98. NINPAN K, Suptawiwat O, Boonarkart C, Songprakhon P, et al
    Mutations in Matrix Protein 1 and Nucleoprotein caused Human-Specific Defects in Nuclear Exportation and Viral Assembly of an Avian Influenza H7N1 Virus.
    Virus Res. 2017 Jun 1. pii: S0168-1702(16)30771.
    PubMed     Abstract available


    April 2017
  99. FULTON RW, Neill JD, Saliki JT, Landis C, et al
    Genomic and antigenic characterization of bovine parainfluenza-3 viruses in the United States including modified live virus vaccine (MLV) strains and field strains from cattle.
    Virus Res. 2017 Apr 14. pii: S0168-1702(17)30110.
    PubMed     Abstract available


  100. IZZARD L, Dlugolenski D, Xia Y, McMahon M, et al
    Enhanced immunogenicity following miR-155 incorporation into the influenza A virus genome.
    Virus Res. 2017 Apr 6. pii: S0168-1702(16)30814.
    PubMed     Abstract available


    March 2017
  101. SELVARANI V, Roland S, Andy S, James H, et al
    Prevention of influenza virus induced bacterial superinfection by standardized Echinacea purpurea, via regulation of surface receptor expression in human bronchial epithelial cells.
    Virus Res. 2017 Mar 6. pii: S0168-1702(16)30783.
    PubMed     Abstract available


    January 2017
  102. PFLUG A, Lukarska M, Resa-Infante P, Reich S, et al
    Structural insights into RNA synthesis by the influenza virus transcription-replication machine.
    Virus Res. 2017 Jan 20. pii: S0168-1702(16)30782.
    PubMed     Abstract available


    November 2016
  103. ABDELWHAB EM, Veits J, Mettenleiter TC
    Biological fitness and natural selection of amantadine resistant variants of avian influenza H5N1 viruses.
    Virus Res. 2016;228:109-113.
    PubMed     Abstract available


    October 2016
  104. KORDYUKOVA L
    Structural and functional specificity of Influenza virus haemagglutinin and paramyxovirus fusion protein anchoring peptides.
    Virus Res. 2016 Oct 20. pii: S0168-1702(16)30406.
    PubMed     Abstract available


    January 2016
  105. ASENJO A, Villanueva N
    Phosphorylation of the human respiratory syncytial virus P protein mediates M2-2 regulation of viral RNA synthesis, a process that involves two P proteins.
    Virus Res. 2016;211:117-25.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: